Detalles de la búsqueda
1.
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients.
Br J Haematol
; 183(1): 35-46, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30010187
2.
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.
Am J Hematol
; 87(1): 22-5, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22086870
3.
Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter studyâ.
Semin Hematol
; 55(4): 248-255, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30502854
4.
Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
Br J Haematol
; 130(6): 878-89, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16156858
Resultados
1 -
4
de 4
1
Próxima >
>>